News and Comments

Onyx (ONXX) Was Right All Along

  Monday, July 26, 2010

In October 2009, Onyx (ONXX) paid $276 million up front to acquire the privately held Proteolix to get to its multiple myeloma drug carfilzomib. It promised $535 million in future payments largely contingent on carfilzomib's approval. As usual, investors did not like Onyx paying money, because investors do not like any company to pay money to develop or acquire state-of-the- art products. When somebody hates something he sees everything in it with pessimism. Onyx put its hands on carfilzomib, which looked very promising for multiple myeloma cases resistant to current treatments. The breakthrough multiple myeloma drugs Velcade (bortezomib) and Revlimid (lenolidamide) could not prevent the cancer from recurring and failed to work at all on a large percentage of recurrent cancer.  More...


Recent Postings


Archive


Tags

SYNTA (SNTA) Regeneron (REGN) Spike Therapeutics (ONCE) GUARDIAN HEALTH Rapamune Intercept (ICPT) OSI (OSIP) Ariad (ARIA) MODERNA Valeant Pharmaceuticals International (VRX) Anadys (ANDS) Theravance Bio Pharma (TBPH) INNOVIVA (INVA) Vertex (VRTX) ZALTRAP™ ARCA (ABIO) VANDA (VNDA) TOKAI (TKAOI) ABBVIE (ABBV) KITE (KITE) BIOMARIN (BMRN) Ridaforolimus Seattle Genetics (SGEN) ISIS (ISIS) REGULUS (RGLS) SUNESIS PHARMACEUTICALS (SNSS) NANTKWEST (NK) PTC Therapeutics (PTCT) ImmunoGen (IMGN) Onyx (ONXX) Sangamo (SGMO) JUNO (JUNO) Bristol-Myers Squibb (BMY) Idenix (IDIX) Sanofi (SNY) AERIE PHARMACEUTICALS IDERA (IDRA) Cytokinetics (CYTK) Intrexon (XON) Sequenom (SQNM) Anacor (ANAC) Revlimid (lenolidamide) Dendreon (DNDN) Vitae Pharmaceuticals (VTAE) Human Genome Sciences (HGSI) Galena (GALE) Mirati Therapeutics (MRTX) KERYX (KERX) Ziofpharm (ZIOP) galapagos (GLPG) Illumina (ILMN) Inovio (INO) GlaxoSmithKline (GSK) Auspex (ASPX) Prosensa (RNA) RenenxBio (RGNX) AstraZeneca (AZN) Gilead (GILD) ARGOS (ARGS) Prolor Biotech (PBTH) Herceptin HALOZYME (HALO) SERES THERAPEUTICS (MCRB) Exelixis (EXEL) Micromet (MITI) Benlysta (belimumab) Sanofi-Aventis (SAN) Xoma (XOMA) AGOS (ARGS) Sarepta (SRPT) Agenus (AGEN Editas (EDIT) Biogen Idec (BIIB) Amgen (AMGN) NOVOCURE (NVCR) Incyte (INCY) Agenus (AGEN) Endometrial Cancer Zerenex Velcade (bortezomib) Roche (RHHBY) Ionis (IONS) CompuGen (CGEN) Global Cell Therapeutics (GBT) Elan (ELN) Theravance (THRX) Alnylam (ALNY) Array Pharmaceuticals (ARRY) Abbott Laboratories (ABT) Human Longevity (HLI) Aimmune Therapeutics (AIMT) Intermune (ITMN) Genentech NEKTAR (NKTR)) Multiple Myeloma Trastuzumab-DM1 Biocryst (BCRX) Jazz Pharmaceuticals (JAZZ) Alder Biopharmaceuticals (ALDR) Roche (ROCHE) Dynavax (DVAX) Telaprevir Merck (MRK) ADVENTRIX (ANX) Sanofi (SNA) ACADIA (ACAD) Pluristem (PSTI) Tysabri C4 Therapeutics